Mr Jon Dubrow > McDermott Will & Emery LLP > Washington DC, United States > Lawyer Profile

McDermott Will & Emery LLP
THE MCDERMOTT BUILDING, 500 NORTH CAPITOL STREET, NW
WASHINGTON, DC 20001-1531
DISTRICT OF COLUMBIA
United States
Jon Dubrow photo

Work Department

Antitrust/Competition

Position

Jon Dubrow is co-head of McDermott’s Antitrust Mergers Focus Group and is a strategic advisor serving clients across a host of inter-related antitrust issues, including mergers and acquisitions (M&A) transactions / merger clearance, counseling and litigation. Jon leads the defense of mergers, acquisitions and joint ventures before the Department of Justice, the Federal Trade Commission and other international competition authorities. He also regularly assists third parties whose interests are adversely affected by proposed transactions. Jon also is experienced in antitrust litigation. He provides counseling on distribution issues, contracting arrangements and a wide variety of other competition-related matters.

Jon obtains clearance in the initial review period even for transactions raising significant substantive issues, avoiding the time and cost of a second request. He takes a very proactive approach in managing the regulatory review process designed to minimize the potential need for an in depth government investigation. He has filed and managed the preparation of hundreds of Hart-Scott-Rodino (HSR) premerger notification forms and regularly provides HSR counseling. He has also managed multinational merger filings in numerous transactions. Jon frequently teams with regional corporate law firms, allowing them to offer sophisticated and seamless antitrust M&A services to their clients when they do not have internal capacity.

Jon counsels clients on a broad range of antitrust issues, including information exchanges, teaming agreements, joint venture ancillary restraints and distribution practices such as pricing restraints, bundled discounting, price discrimination, exclusive distribution, dealer termination and exclusive dealing.

Jon has defended a wide variety of antitrust claims in litigation, including Sherman Act monopolization and conspiracy claims involving alleged price fixing, market allocation, tying, “bundled discounts,” “aftermarket” parts and services, theft of trade secrets, defamation, other business torts and other alleged anticompetitive conduct. He also defends governmental challenges to acquisitions under Section 7 of the Clayton Act.

Jon has handled antitrust issues in scores of different industries. He has a particularly strong background in several industry-based representations covering multiple matters, including aerospace and defense, pharmaceuticals / biologic products, medical devices, construction products, and consumer products such as beer, wine, beverage alcohol and cannabis.

Lawyer Rankings

United States > Antitrust > Merger control

McDermott Will & Emery LLP is noted for its high-level specialist healthcare antitrust and FTC practices, combining a steady stream of HSR filings and merger approvals with standout capabilities in government merger investigations and litigation, also working regularly on transactions in the tech and defense sectors, among others. The team includes diverse merger and contentious antitrust experts, with practice head Raymond Jacobsen working on major US and international mandates in industries including defense, medical devices, and biotech, while former FTC Mergers II lawyer Joel Grosberg has a strong knowledge of FTC and DOJ merger processes, advising on acquisitions, sales, and joint ventures. Jon Dubrow is a prolific HSR counsel and also focuses on securing first-stage approvals for highly scrutinized deals, Gregory Heltzer stands out for his merger defense work, and Lisa Rumin has also seen success in defending mergers in the healthcare, pharma, and biotech against investigations by state and federal authorities. Chicago’s Stephen Wu  plays a key role in the firm’s health antitrust offering. All lawyers mentioned are in Washington DC unless otherwise stated.